Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Anuradha Mascarenhas Posted: Sep 21, 2008 at 0118 hrs IST Pune, September 20 Paracetamol, a widely prescribed drug for fever and pain, has come under the scanner with a global study showing that its use in the first year of life is associated with the risk of asthma and eczema …
Y.Mallikarjun HYDERABAD: A representative of the Sweden-based WHO Collaborating Centre for International Drug Monitoring has expressed concern that the
Business Standard / New Delhi September 19, 2008, 5:53 IST While the debate over the safety and efficacy of clinical trials in the country continues, another controversy has surfaced. The Indian edition of the Monthly Index of Medical Specialities (MIMS) has accused the Drugs Controller General of India (DCGI) of …
THE U.S. BAN ON some medicines made by India's largest pharmaceutical company adds a black mark against India's booming drug and drug-testing industries, which already have been under pressure over the country's lax monitoring of drug safety. India's pharmaceutical industry was once the nemesis of U.S. drug companies, producing knock-off …
Joe C Mathew / New Delhi September 18, 2008, 0:04 IST The World Health Organization (WHO) has not approved any new vaccine from India this year as the Indian regulatory system, which gives manufacturing licences for domestic vaccines, has failed to meet its quality benchmarks. Companies like Shanta Biotech, Panacea …
Lapses on record-keeping Affects numerous, widely-used medications Preventive action to protect quality of drugs WASHINGTON: U.S. health officials have blocked dozens of drugs made by Ranbaxy Laboratories after the generic drugmaker failed to fix numerous record-keeping and other operational problems, although the medications themselves are considered safe. The U.S. Food …
NEW DELHI: The Council of Scientific and Industrial Research on Monday launched a new initiative to develop low cost drugs for infectious diseases like tuberculosis that afflict mainly the poor in India and other developing countries. Big pharmaceutical companies do not spare much resources for these for want of adequate …
Reema Narendran |THIRUVANANTHAPURAM: Without a thought to the human effort, time and money put into its validation, two tribal medicines developed in the state are disappearing into nothingness, while multinational pharma companies walk away with the patents and trademark rights. On the one hand is Jeevani, which has already lost …
In a path-breaking initiative that has the potential to revolutionalise the drug manufacturing sector, the Council of Scientific and Industrial Research (CSIR) on Monday launched its Open Source Drug Discovery (OSDD) programme with the aim of finding a cheap medicine for tuberculosis. The main objective of the initiative is to …
Nina Mehta & Kiran Kabtta MUMBAI THE government has begun speeding up approvals in the area of clinical research which is set to boom in India, say top industry sources. The clinical research industry in India is currently $200 million, but is expected to reach $1.5 billion in just two …
>> The Bihar government will set up a community radio station, the first for farmers in the state. Decks have been cleared for setting up the community radio station following clearance by the central government and approval of funding for it. Bihar
P B Jayakumar / Mumbai September 12, 2008, 0:42 IST Avesta Biotherapeutics and Research (ABRPL), the 50:50 joint venture between Cipla group company Meditab Specialities and Bangalore-based Avestha Gengraine Technologies (Avesthagen), is targeting to launch about eight high-value, bio-similar or copied versions of off-patent biotech drugs before 2012. ABRPL is …
Bs Reporter / Mumbai September 12, 2008, 0:09 IST The Central government is planning to enforce stringent regulations for improving standards for human clinical trials conducted for medical devices, Surinder Singh, Drug Controller General of India (DCGI), said. The regulator, which is planning to allow first phase of human clinical …
Joe C Mathew / New Delhi September 12, 2008, 0:23 IST An expert committee of the health ministry which looked into reviving three government vaccine units that were closed down has recommended converting two of these units into centres for producing yellow fever vaccine capable of serving global needs. The …
R. PRASAD High cost to treat cancer engenders willingness to pay for vaccine A formative study was completed recently to understand the various facets of the society and health systems prior to introducing a vaccine that can prevent Human papillomavirus (HPV) infection that is responsible for causing cervical cancer in …
Rema Nagarajan | TIG If a disease can be treated for Rs 10, why would you spend Rs 12,000 for it? That is the question being raised by some doctors on a move to make a vaccine against pneumonia part of the immunisation programme. According to WHO protocol, pneumonia in …
Are there public health consequences when regulators turn a blind eye to cross border advertising that contravenes national laws? Although Canada prohibits direct to consumer advertising of prescription drugs, no steps are taken to prevent US advertising from reaching the Canadian public. The linked study by Law and colleagues (doi: …
Companiese that advertise prescription drugs directly to consumers may not get as much bang for their buck as they - or their critics - assume. Direct-to-consumer advertising (DTCA) of drugs is only permitted in the US and New Zealand and has long been controversial. Both proponents and opponents assume the …
